Recombinant Butyrylcholinesterases and Truncates Thereof
AssigneePharmAthene, Inc.
InventorsKalvin Yim, Steven Danso, Edward Hausknecht
Life of this patent
Estimating the term…
Abstract
Isolated nucleic acids encoding polypeptides that exhibit butyrylcholinesterase (BChE) enzyme activity are disclosed, along with molecular criteria for preparing such nucleic acids, including codon optimization. Methods of preparing modified and/or truncated BChE molecules having selected properties, especially selective formation of monomers, are also described. Vectors and cells containing and/or expressing the nucleic acids are also disclosed.
Claims40
An isolated nucleic acid that encodes a polypeptide having BChE enzyme activity, wherein the percentage of guanine plus cytosine (G+C) nucleotides in the coding region of said nucleic acid is greater than 40% but not greater than 80%.
Dependencies are inferred from the claim text.